First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

Conditions: Advanced Cancer; Breast Cancer Interventions: Drug: OKI-219; Drug: Fulvestrant; Drug: Trastuzumab Sponsors: OnKure, Inc. Not yet recruiting

https://clinicaltrials.gov/study/NCT06239467

Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials